Pfizer Inc stock price prediction is an act of determining the future value of Pfizer shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Pfizer’s future price could yield a significant profit.
The 19 analysts offering 12-month price forecasts for Pfizer Inc have a median target of 55.00, with a high estimate of 76.00 and a low estimate of 49.00. The median estimate represents a +12.11% increase from the last price of 49.06.
Why is PFE going down?
Apr 15, 2022 · Pfizer Stock Forecast, Price & News $48.45 -1.21 (-2.44%) (As of 05/5/2022 04:02 PM ET) Today’s Range $47.55 $49.55 50-Day Range $45.75 $55.17 52-Week Range $37.96 $61.71 Volume 28.31 million shs Average Volume 31.87 million shs Market Capitalization $273.63 billion P/E Ratio 11.11 Dividend Yield 3.22% Beta 0.76 Profile Analyst Ratings Chart
Will PFE stock split soon?
Oct 15, 2020 · About the Pfizer Inc. stock forecast. As of 2022 May 03, Tuesday current price of PFE stock is 47.760$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Pfizer stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame.. Our site uses …
Why is PFE dropping?
Mar 25, 2022 · If you are looking for stocks with good return, Pfizer Inc. can be a profitable investment option. Pfizer Inc. quote is equal to 52.190 USD at 2022-03-24. Based on our forecasts, a long-term increase is expected, the “PFE” stock price prognosis for 2027-03-19 is 64.125 USD. With a 5-year investment, the revenue is expected to be around +22.87%.
Why Pfizer is down?
The 19 analysts offering 12-month price forecasts for Pfizer Inc have a median target of 55.00, with a high estimate of 76.00 and a low estimate of 49.00. The median estimate represents a …
Is PFE a Buy Sell or Hold?
Why is PFE going down?
Is Pfizer a buy Zacks?
Is Pfizer delisting from Nasdaq?
Is Pfizer a buy right now?
19 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Pfizer in the last year. There are currently 9 hold ratings and…
How has Pfizer’s stock been impacted by Coronavirus (COVID-19)?
Pfizer’s stock was trading at $32.17 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organiza…
When is Pfizer’s next earnings date?
Pfizer is scheduled to release its next quarterly earnings announcement on Tuesday, May 3rd 2022. View our earnings forecast for Pfizer .
How were Pfizer’s earnings last quarter?
Pfizer Inc. (NYSE:PFE) released its earnings results on Tuesday, February, 8th. The biopharmaceutical company reported $1.08 EPS for the quarter, b…
How often does Pfizer pay dividends? What is the dividend yield for Pfizer?
Pfizer announced a quarterly dividend on Friday, December 10th. Stockholders of record on Friday, January 28th will be paid a dividend of $0.40 per…
Is Pfizer a good dividend stock?
Pfizer pays an annual dividend of $1.60 per share and currently has a dividend yield of 3.02%. Pfizer has been increasing its dividend for 12 conse…
What guidance has Pfizer issued on next quarter’s earnings?
Pfizer issued an update on its FY 2022 earnings guidance on Tuesday, February, 22nd. The company provided EPS guidance of $6.350-$6.550 for the per…
What price target have analysts set for PFE?
19 Wall Street analysts have issued twelve-month target prices for Pfizer’s stock. Their forecasts range from $44.00 to $76.00. On average, they an…
Who are Pfizer’s key executives?
Pfizer’s management team includes the following people: Dr. Albert Bourla D.V.M. , DVM, Ph.D., Chairman & CEO (Age 60, Pay $7.99M) Mr. Frank A….
“Should I invest in
Pfizer stock?” “Should I trade “PFE” stock today?”
According to our live Forecast System,
Pfizer Inc. stock is
a good long-term (1-year)
investment *.
What is
the Pfizer stock price / share price today?
The Pfizer stock price is
45.675
USD today.
Will Pfizer stock price grow / rise / go
up?
Yes. The PFE stock price can go up
from
45.675 USD to
50.475 USD in…
Is it profitable to
invest in Pfizer stock?
Yes. The long-term earning potential is
+ 10.51 %
in one year.
Will PFE stock price fall / drop?
No. See above .
What
will Pfizer stock price be worth in five years
(2027)?
The PFE (“PFE” )
future stock price will be
57.410 USD .
Will PFE stock price crash?
According to our analysis, this will not happen.
Will Pfizer stock price
hit 100 USD price in a year?
Not within a year.
See above .
Will Pfizer stock price
hit 200 USD price in a year?
Not within a year.
See above .
Stock Price Forecast
The 21 analysts offering 12-month price forecasts for Pfizer Inc have a median target of 57.00, with a high estimate of 76.00 and a low estimate of 49.00. The median estimate represents a +16.54% increase from the last price of 48.91.
Analyst Recommendations
The current consensus among 25 polled investment analysts is to Hold stock in Pfizer Inc. This rating has held steady since February, when it was unchanged from a Hold rating. Move your mouse over past
months for detail
Historical and forecast chart of Pfizer stock
The chart below shows the historical price of Pfizer stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Pfizer stock price can be found in the table below.
Pfizer Daily Price Targets
Forecast target price for 02-24-2022: $ 49.35. Positive dynamics for Pfizer shares will prevail with possible volatility of 3.586%.
Pfizer information and performance
Pfizer, Inc. is an American pharmaceutical company, one of the largest in the world. The company produces the following popular medicines: Lipitor, Lyrica, Diflucan, Zitromax, Viagra, Celebrex, Sermion, Dostinex, Champix.
Pfizer (PFE) stock dividend
Pfizer last paid dividends on 01/27/2022. The next scheduled payment will be on 03/04/2022. The amount of dividends is $1.56 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data.
Pfizer Inc Stock Forecast
Over the next 52 weeks, Pfizer Inc has on average historically risen by 10.9 % based on the past 48 years of stock performance.
Will Pfizer Inc Stock Go Up Next Year?
Over the next 52 weeks, Pfizer Inc has on average historically risen by 10.9% based on the past 48 years of stock performance.
Pfizer Inc Stock Price History
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PFE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Stock Predictions
Is Pfizer Inc stock public?
Yes, Pfizer Inc is a publicly traded company.
PFE : Pfizer stock forecast by Wall Street Analysts
The average Pfizer stock forecast from last 6 month is $54.82, and this show a 11.92% increase in average from the prior price target of the each prediction. Also, this average forecast of $54.82 represents a 28.99% increase from the past average forecast of $42.5, 6 months ago from 10 wall street analysts.
Frequently Asked Questions about Pfizer stock forecast
From Pfizer stock forecast , Pfizer (PFE) stock cannot be a good investment choice. According to AI Pickup, the Pfizer stock price forecast for 2022 Mar. is $48.0442529280047
Signals & Forecast
There are few to no technical positive signals at the moment. The Pfizer Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Support, Risk & Stop-loss
There is no support from accumulated volume below today’s level and given the right condition the stock may perform very badly in the next couple of days.
Is Pfizer Inc stock A Buy?
Pfizer Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Insiders are negative selling more shares than they are buying in Pfizer Inc
In the last 100 trades there were 418.15 thousand shares bought and 817.18 thousand shares sold. The last trade was done 6 days ago by Johnson Rady A who bough 190 shares. In general the insiders are selling more stocks than they buy. There can be a variety of reasons for this, but in general it can be considered as a negative signal.
About Pfizer Inc
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Is Pfizer stronger than Upjohn?
Thanks to the recent merger of the company’s former Upjohn unit with Mylan, Pfizer is in a stronger position to grow than it has been in for quite a while.
Does Bourla have a BNT162B2?
It’s important to note that Bourla’s 6% annual growth figure doesn’t include any impact from BNT162b2, the COVID-19 vaccine developed by Pfizer and its partner, BioNTech. The two companies recently filed a request for an emergency use authorization with the FDA.
Is Pfizer a wild card?
Wild cards. If everything moves forward based on how things look right now, Pfizer probably will generate mid-single-digit-percentage annual sales growth and even stronger earnings growth. However, there are always extra wild cards for pharmaceutical companies .
Is Pfizer generating sales growth?
If everything moves forward based on how things look right now, Pfizer probably will generate mid-single-digit-percentage annual sales growth and even stronger earnings growth. However, there are always extra wild cards for pharmaceutical companies .
How many programs are Pfizer awaiting approval?
One obvious uncertainty is how well its pipeline candidates will pan out. Pfizer’s currently awaiting regulatory approval decisions for six programs.
Is Pfizer awaiting regulatory approval?
One obvious uncertainty is how well its pipeline candidates will pan out. Pfizer’s currently awaiting regulatory approval decisions for six programs. Two of those are fairly important to the company’s future: abrocitinib in treating atopic dermatitis and tanezumab in treating osteoarthritic pain.
How many programs does Pfizer have?
Pfizer’s pipeline also includes 21 late-stage programs.
